Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Stem Cell Research

Free Subscription Articles published in Leuk Res Retrieve available abstracts of 29 articles: HTML format

Single Articles

May 2026
1. SAWIRIS M, Patel A, Anders B, Wofford A, et al
   Non-myeloablative conditioning regimens: Fludarabine/busulfan or fludarabine/cyclophosphamide/total body irradiation for allogeneic stem cell transplant.
   Leuk Res. 2026;166:108253.
   PubMed    
   
   
   April 2026
2. SCHUTTE D, Call EM, Furstenau M, Beckmann L, et al
   Retrospective, single-center analysis of second allogeneic stem cell transplantation versus non-transplant regimens for acute myeloid leukemia patients with relapse after first transplantation.
   Leuk Res. 2026;165:108228.
   PubMed     Abstract available
   
   
   
3. YAMAMOTO J, Yamamoto H, Watanabe O, Kuno M, et al
   Outcomes and prognostic factors of hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and central nervous system involvement.
   Leuk Res. 2026;165:108226.
   PubMed     Abstract available
   
   
   March 2026
4. LU W, He Z, Huang X
   Integrative transcriptomic and machine learning analysis identifies core immune genes and pathways driving graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
   Leuk Res. 2026;163:108201.
   PubMed     Abstract available
   
   
   February 2026
5. MOOTOOSAMY C, Ansari M, Gagne V, Chatelain-Laflamme A, et al
   IL1B rs1143627 and IL17A rs8193036 in the risk of Acute Graft Versus Host Disease in pediatric HSCT.
   Leuk Res. 2026;163:108189.
   PubMed     Abstract available
   
   
   
6. WANG WJ, Wang SA, Al-Atrash G, Fang H, et al
   T-cell mixed chimerism after allogeneic hematopoietic stem cell transplantation does not correlate with relapse in patients with acute myeloid leukemia.
   Leuk Res. 2026;162:108185.
   PubMed    
   
   
   
7. HOU HA, Getta B, Ahn JS, Elsouda D, et al
   Outcomes of patients with R/R FLT3(mut+) AML treated with maintenance gilteritinib therapy after hematopoietic stem cell transplantation.
   Leuk Res. 2026;162:108186.
   PubMed     Abstract available
   
   
   January 2026
8. KHAN A, Gajendra S, Singh VK, Thakral D, et al
   Single cell transcriptomics derived combinatorial markers distinguished leukemic stem cells from hematopoietic stem cells in acute myeloid leukemia.
   Leuk Res. 2026;161:108170.
   PubMed     Abstract available
   
   
   December 2025
9. RONNACKER J, Urbahn MA, Reicherts C, Kolloch L, et al
   Relapse after allogeneic hematopoietic stem cell transplantation in patients with active acute myeloid leukemia.
   Leuk Res. 2025;160:108153.
   PubMed     Abstract available
   
   
   
10. BHATIA I, Patel S, Pearson L, Parthiban K, et al
    Outcomes of adults older than 70 years of age undergoing allogeneic stem cell transplantation.
    Leuk Res. 2025;160:108145.
    PubMed     Abstract available
    
    
    November 2025
11. KOJO K, Sadato D, Toya T, Oboki K, et al
    NGS-based quantitative typing to identify HLA loss relapse after allogeneic stem cell transplantation.
    Leuk Res. 2025;160:108135.
    PubMed    
    
    
    
12. ITONAGA H, Miyazaki Y, Fujioka M, Kurosawa S, et al
    Differential impact of graft-versus-host disease on post-transplant outcomes of chronic myelomonocytic leukemia according to transplant procedures.
    Leuk Res. 2025;159:108134.
    PubMed     Abstract available
    
    
    October 2025
13. LI J, Li F, Zhang M, Wu Y, et al
    Exosomal miR-140-3p produced by bone marrow stromal cells affects acute myeloid leukemia cell growth and apoptosis by targeting SUZ12.
    Leuk Res. 2025;159:108122.
    PubMed     Abstract available
    
    
    September 2025
14. YAP S, Kelly A, Goldsbury D, Weber MF, et al
    Health system costs and autologous stem cell transplant receipt for participants with multiple myeloma in the Australian 45 and Up Study.
    Leuk Res. 2025;158:108100.
    PubMed     Abstract available
    
    
    August 2025
15. YANG Q, Ding Z, Liu Y, Chen S, et al
    Effect of sorafenib on prognosis in patients with low-allelic-ratio FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation.
    Leuk Res. 2025;157:108088.
    PubMed     Abstract available
    
    
    June 2025
16. AMIN MK, Khan MA, Khan FH, Zakir A, et al
    Impact of FLT3 inhibitors on the outcomes of FLT3-ITD mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant: A systematic review and meta-analysis.
    Leuk Res. 2025;155:107724.
    PubMed     Abstract available
    
    
    May 2025
17. LI X, Cai Y, Yang J, Huang C, et al
    Parous female donor is not inferior to the young male donor under the low-dose ATG/PTCy combination-based regimen for GVHD prophylaxis in haploidentical peripheral blood stem cell transplantation.
    Leuk Res. 2025;154:107721.
    PubMed     Abstract available
    
    
    April 2025
18. AUBREY BJ, Blonquist T, McMasters M, Hobbs G, et al
    A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation.
    Leuk Res. 2025;153:107693.
    PubMed     Abstract available
    
    
    January 2025
19. CHO H, Kim J, Park Y, Lee BH, et al
    The presence of clonal isotype switch after autologous stem cell transplantation as a prognostic biomarker for long-term survival in patients with multiple myeloma.
    Leuk Res. 2025;149:107641.
    PubMed     Abstract available
    
    
    December 2024
20. SHAHZAD M, Iqbal Q, Amin MK, Irfan S, et al
    Outcomes of hematopoietic stem cell transplantation in primary plasma cell leukemia: A systematic review and meta-analysis.
    Leuk Res. 2024;148:107640.
    PubMed     Abstract available
    
    
    November 2024
21. ROUZBAHANI M, Mousavi SA, Hajianfar G, Ghanaati A, et al
    Predictive modeling of outcomes in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation using machine learning techniques.
    Leuk Res. 2024;148:107619.
    PubMed     Abstract available
    
    
    
22. LUCCHINI G, Cozma E, Jackson A, Gilmour K, et al
    COVID-19 infection in adult and paediatric recipients of allogeneic stem cell transplantation: The UK experience.
    Leuk Res. 2024;147:107618.
    PubMed    
    
    
    
23. HUANG X, Wu X, Wang S, Ren Y, et al
    Thiotepa-busulfan-fludarabine conditioning as a promising approach prior to haploidentical allogeneic hematopoietic stem cell transplantation in hematological malignancies with extramedullary involvement: Insights from a single center.
    Leuk Res. 2024;147:107617.
    PubMed    
    
    
    October 2024
24. WAIS V, Gantner A, Strauss K, Neagoie A, et al
    Treatment of steroid-refractory acute/chronic graft versus host disease: A single-center real-world experience of ruxolitinib in combination with extracorporeal photopheresis in a high-risk population.
    Leuk Res. 2024;147:107611.
    PubMed     Abstract available
    
    
    August 2024
25. SHIMIZU H, Kato J, Tanoue S, Kimura SI, et al
    Allogeneic stem cell transplant with TBI-based myeloablative conditioning in adolescents and young adults with Philadelphia chromosome-negative ALL treated with pediatric protocols.
    Leuk Res. 2024;144:107562.
    PubMed     Abstract available
    
    
    April 2024
26. INDRAN T, Das T, Muirhead J, O'Brien M, et al
    Donor Lymphocyte Infusion (DLI) post allogeneic stem cell transplant (allo-SCT) in Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndrome (MDS). A longitudinal retrospective study using peripheral blood (PB) CD34(+) and CD3(+) donor chim
    Leuk Res. 2024;142:107504.
    PubMed     Abstract available
    
    
    
27. ASHOURI K, Ginosyan AA, Chu M, Hom B, et al
    Donor matters: Donor selection impact on hematopoietic stem cell transplantation outcomes in Hispanic patients with B-cell acute lymphocytic leukemia: Insights from a myeloablative HSCT study.
    Leuk Res. 2024;141:107501.
    PubMed     Abstract available
    
    
    March 2024
28. BRUNETTI M, Iasenza IA, Jenner AL, Raynal NJ, et al
    Mathematical modelling of clonal reduction therapeutic strategies in acute myeloid leukemia.
    Leuk Res. 2024;140:107485.
    PubMed     Abstract available
    
    
    
29. KILIC GUNES E, Yigit Kaya S, Yaman F, Yeniay MK, et al
    Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience.
    Leuk Res. 2024;140:107484.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum